Compare, Analyse Sun Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs MYLAN (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   MYLAN
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
MYLAN
Dec-18
SUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6793,382-   
Low Rs3751,861-   
Sales per share (Unadj.) Rs121.11,556.0-  
Earnings per share (Unadj.) Rs13.442.3-  
Cash flow per share (Unadj.) Rs20.7333.6-  
Dividends per share (Unadj.) Rs2.750-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs172.61,683.3-  
Shares outstanding (eoy) m2,399.26514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.7 258.3%   
Avg P/E ratio x39.462.0 63.5%  
P/CF ratio (eoy) x25.57.9 324.3%  
Price / Book Value ratio x3.11.6 196.1%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m1,264,6501,348,698 93.8%   
No. of employees `00017.535.0 50.0%   
Total wages/salary Rs m59,6710-   
Avg. sales/employee Rs Th16,608.122,872.9 72.6%   
Avg. wages/employee Rs Th3,409.60-   
Avg. net profit/employee Rs Th1,833.8621.1 295.3%   
INCOME DATA
Net Sales Rs m290,659800,550 36.3%  
Other income Rs m10,2550-   
Total revenues Rs m300,914800,550 37.6%   
Gross profit Rs m63,076207,153 30.4%  
Depreciation Rs m17,533149,894 11.7%   
Interest Rs m5,55338,504 14.4%   
Profit before tax Rs m50,24618,755 267.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,1440-   
Tax Rs m6,009-2,984 -201.4%   
Profit after tax Rs m32,09321,738 147.6%  
Gross profit margin %21.725.9 83.9%  
Effective tax rate %12.0-15.9 -75.2%   
Net profit margin %11.02.7 406.6%  
BALANCE SHEET DATA
Current assets Rs m310,692447,026 69.5%   
Current liabilities Rs m173,396325,932 53.2%   
Net working cap to sales %47.215.1 312.3%  
Current ratio x1.81.4 130.6%  
Inventory Days Days9984 118.5%  
Debtors Days Days11293 119.6%  
Net fixed assets Rs m232,477155,293 149.7%   
Share capital Rs m2,399426 562.9%   
"Free" reserves Rs m411,6910-   
Net worth Rs m414,091866,049 47.8%   
Long term debt Rs m15,226934,744 1.6%   
Total assets Rs m646,9382,323,079 27.8%  
Interest coverage x10.01.5 675.8%   
Debt to equity ratio x01.1 3.4%  
Sales to assets ratio x0.40.3 130.4%   
Return on assets %5.82.6 224.4%  
Return on equity %7.82.5 308.8%  
Return on capital %10.23.2 319.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m27,4150-   
CASH FLOW
From Operations Rs m21,965166,354 13.2%  
From Investments Rs m-6,813-85,987 7.9%  
From Financial Activity Rs m-27,305-77,498 35.2%  
Net Cashflow Rs m-8,4421,378 -612.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare SUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: WYETH LTD  DR. REDDYS LAB  NATCO PHARMA  TORRENT PHARMA  ALEMBIC LTD  



Today's Market

Sensex Opens Higher; Consumer Durables and Energy Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.7% while the Hang Seng is down 0.1%.

Related Views On News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Oct 15, 2019 11:57 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS